研究生: |
張溫倪 Stephanie - Rosanto |
---|---|
論文名稱: |
The Essentials of High-Growth Company: A Case Study of Pfizer Limited Taiwan The Essentials of High-Growth Company: A Case Study of Pfizer Limited Taiwan |
指導教授: |
劉代洋
Day-Yang Liu |
口試委員: |
張琬喻
none 王淑滿 none |
學位類別: |
碩士 Master |
系所名稱: |
管理學院 - 管理學院MBA School of Management International (MBA) |
論文出版年: | 2013 |
畢業學年度: | 102 |
語文別: | 英文 |
論文頁數: | 87 |
中文關鍵詞: | Not Available |
外文關鍵詞: | market segments, value preposition, Pfizer Ltd. Taiwan, Pfizer Inc., leadership and management team |
相關次數: | 點閱:251 下載:0 |
分享至: |
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報 |
Not Available
Pfizer Incorporated is the largest multinational Pharmaceutical Company. Its headquarters is located in United States of America, and they have with 530 subsidiaries in 150 countries, including Taiwan. Pfizer have been the leading Pharmaceutical Company with the most Revenues for many years, and in term of revenue they have earned more than what other Pharmaceutical Companies could have earned. However ever since Pfizer suffered decline in Revenue in 2012, Novartis has taken over its leading position. Despite of the recent downturn, it still does not change the fact that Pfizer Inc. has already achieved more them US$ 1 billion Exponential Return since years ago. Therefore, Pfizer Inc. is one of the Blueprints for the High-Growth Companies.
This study case is conducted to analyze they relations between the Seven Essentials to Achieve Exponential Growth by David G. Thomson and the success of Pfizer Inc. and Pfizer Ltd. Taiwan. With the Value Prepositions as the foundation of essentials, implementation of Market Segments, identification of real Marquee Customers, establishment of powerful Strategic Alliances, successful achievement of Exponential Returns, and solid Leadership formation within the Management Team and the Board Members, Pfizer Inc. are able to attain High-Growth, maintain performance and become one of the Giants.
Albright, K., 2010, ‘Can Pfizer Maintain Success In The U.S. Pharmaceutical Industry’, SlideShare Inc., April 22, viewed 28 November 2013 <http://www.slideshare.net/AileenMarshall/business-report-on-pfizer?from_search=15>
Bartlett, C.A. & Beamish, P.W., 2010, Transnational Management: Text, Cases, and Readings in Cross-Border Management, 6th edn, McGraw-Hill Higher Education, New York City, New York, United States of America
Blueprint Growth Institute, Inc., 2010, “Blueprint Companies”, Blueprint Growth Institute, Inc., viewed 28 November 2013 <http://www.blueprintgrowth.com/index.html>
Boldrin, M. & Levine, D.K., 2010, Against Intellectual Monopoly. Cambridge University Press, Cambridge, United Kingdom
Conroy, P., Chaudhuri, A. & Hukumchand, V., 2009, ‘Maximizing ROIC to Drive Growth in Consumer Products: Learning from the past, preparing for the future’, Delloite Development LLC, viewed 25 November 2013 <http://www.deloitte.com/view/en_us/us/d8dc8dfbf5f94210VgnVCM200000bb42f00aRCRD.htm >
Current Partnering, 2013a, ‘M&A deal activity’, Wildwood Ventures Ltd., viewed 26 November 2013 <http://www.currentpartnering.com/scorecard/deal-metrics/ma-deal-activity/>
Current Partnering, 2013b, ‘M&A scorecard’, Wildwood Ventures Ltd., viewed 26 November 2013 <http://www.currentpartnering.com/scorecard/ma/>
Current Partnering, 2013c, ‘Deal metrics’, Wildwood Ventures Ltd., viewed 26 November 2013 <http://www.currentpartnering.com/scorecard/deal-metrics/>
EFPIA, 2013, ‘The Pharmaceutical Industry in Figures’, EFPIA, viewed 26 November 2013 <http://www.efpia.eu/uploads/Figures_Key_Data_2013.pdf>
Gauntlett, C. & Rickwood, S., 2013, ‘The changing face of the top 10 pharmaceutical companies: The beginning of the end for innovative dominance’, IMS Health Inc., viewed 25 November 2013 <http://www.imshealth.com/deployedfiles/ims/Global/Asia%20Pacific/Content/Insights/Top10%20Pharma%20Companies%20WP%20final_for%20clients.pdf>
Google Finance, 2013, ‘Pfizer Inc.’, Google, viewed 3 December 2013 <http://www.google.com/finance?chdnp=0&chdd=0&chds=0&chdv=0&chvs=maximized&chdeh=0&chfdeh=0&chdet=1386077566301&chddm=3621051&chls=IntervalBasedLine&q=NYSE%3APFE&ntsp=0&fct=big&ei=I9udUqj-F86ZlQXYZg>
Harris, G., 2009, ‘Pfizer Pays $2.3 Billion to Settle Marketing Case’, The New York Times Company, September 2, viewed 29 November 2013 <http://www.nytimes.com/2009/09/03/business/03health.html>
Hitt, M.A., Ireland, R.D. & Hoskisson, R.E., 2011, The Management of Strategy: Concepts and Cases, International Edition, 9th edn, Cengage Learning, Stamford, Connecticut, United States of America
Hoyer, W.D. & MacInnis, D.J., 2001, Consumer Behaviour, 2nd edn, Houghton Mifflin Harcourt, Boston, Massachusetts, United States of America
Huang, Y.C., 2009, ‘Global Biomedical Industry Market Movement and Development Opportunity in Taiwan’, Department of Investment Services, MOEA, November 11, viewed 26 November 2013 <http://investtaiwan.org/eng/ind_news_display.jsp?newsid=3>
IMS Health Inc., 2013, ‘Top Line Market Data’, IMS Health Inc., viewed 28 November 2013 <http://www.imshealth.com/portal/site/ims/menuitem.5ad1c081663fdf9b41d84b903208c22a/?vgnextoid=fbc65890d33ee210VgnVCM10000071812ca2RCRD>
Investopedia, 2013, ‘Dictionary’, Investopedia US, A Division of ValueClick, Inc., viewed 29 November 2013 <http://www.investopedia.com/dictionary/>
Jeannet, J. P. & Hennessey, H. D., 1998, Global Marketing Strategies, 4th edn, Houghton Mifflin, Boston, Massachusetts, United States of America
McNiel Jr., D.G., 2011, ‘Nigerians Receive First Payments for Children Who Dies in 1996 Meningitis Drug Trial’, New York Times Company, August 11, viewed 30 November 2013 <http://www.nytimes.com/2011/08/12/world/africa/12nigeria.html?_r=0 >
NYSE EURONEXT, 2013, ‘Pfizer Inc.’, NYSE EURONEXT, viewed 28 November 2013 <http://www.nyse.com/about/listed/lcddata.html?ticker=pfe>
Pearson Education, Inc., 2010, ‘Market Segmentation and Strategic Targeting’, Prentice Hall, viewed 28 November 2013 <http://home.kku.ac.th/petmas/Segmenting%20and%20Targeting.pdf>
Pfizer Inc., 2010, Pfizer Inc., viewed 23 November 2013 <http://www.pfizer.com.tw/index.asp>
Pfizer Inc., 2013, Pfizer Inc., viewed 23 November 2013 <http://www.pfizer.com/>
PhRMA, 2013, ‘PhRMA: Profile 2013’. Pharmaceutical Research and Manufacturers of America, viewed 27 November 2013 <http://phrma.org/sites/default/files/pdf/PhRMA%20Profile%202013.pdf>
Skok, M., 2013, ‘4 Steps To Building A Compelling Value Proposition’, Forbes.com, June 14, viewed 28 November 2013 <http://www.forbes.com/sites/michaelskok/2013/06/14/4-steps-to-building-a-compelling-value-proposition/>
Stock Analysis on Net, 2013, ‘Pfizer Inc. (PFE)’, EBIT Financial Analyses Centre, viewed 31 November 2013 <http://www.stock-analysis-on.net/NYSE/Company/Pfizer-Inc>
The China Post, 2013, ‘Pfizer’s Hsinchu factory is biggest in Taiwan’, The China Post, February 27, viewed 28 November 2013 <http://www.chinapost.com.tw/taiwan/business/2010/02/27/246098/Pfizers-Hsinchu.htm>
Thomson, D.G., 2005, ‘The Blueprint Thesis: A Different Approach to Growth’, Blueprint Growth Institute, Inc., viewed 23 November 2013 <http://www.blueprintgrowth.com/business_growth_books/blueprint_to_a_billion/downloads/chapterone.pdf>
Thomson, D.G., 2006, Blueprint to A Billion: 7 Essentials to Achieve Exponential Growth, John Wiley & Sons, Inc., Hoboken, New Jersey, United States of America
Thomson, D.G., 2010, Mastering The 7 Essentials of High-Growth Companies, John Wiley & Sons, Inc., Hoboken, New Jersey, United States of America
Torres, E.M., 2010, ‘Financial Research: Johnson and Johnson and Pfizer Company, Risks, Stock Analysis’, SlideShare Inc., viewed 29 November 2013 <http://www.slideshare.net/Erick_Martinez/fiancial-research>
Wedel, M. & Kamakura, W., 2002, ‘Introduction to the Special Issue on Market Segmentation’, International Journal in Research in Marketing 19, Page 181-183, Elsevier Ltd., viewed 28 November 2013 <http://wak2.web.rice.edu/bio/My%20Reprints/IntroductiontothespecialissueonMarketSegmentation.pdf>